about
Animal Eye Models for Uveal MelanomaCurrent State of Animal (Mouse) Modeling in Melanoma ResearchMetabotropic glutamate receptors (mGlus) and cellular transformation.Vasculogenic mimicry and tumor angiogenesis.Modeling the behavior of uveal melanoma in the liver.Transgenic mouse models for tumors of melanocytes and retinal pigment epithelium.Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progressionBronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor.Tumor vascularity and hematogenous metastasis in experimental murine intraocular melanoma.Photobiology and genetics of malignant melanoma.Cooperative effects of INK4a and ras in melanoma susceptibility in vivo.Molecular basis of dark-eyed albinism in the mouse.Id2 deficiency promotes metastasis in a mouse model of ocular cancer.UVB induces atypical melanocytic lesions and melanoma in human skin.Activated ras. Yet another player in melanoma?Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion geneTransgenic mouse model of malignant skin melanomaHistopathogenesis of malignant skin melanoma induced in genetically susceptible transgenic mice.Genetics of melanomaUp-regulation of specific tyrosinase mRNAs in mouse melanomas with the c2j gene substituted for the wild-type tyrosinase allele: utilization in design of syngeneic immunotherapy models.Targeting events in melanoma carcinogenesis for the prevention of melanoma.Predominant formation of heavily pigmented dermal melanocytomas resembling 'animal-type' melanomas in hepatocyte growth factor (C57BL/6 x C3H)F1 mice following neonatal UV irradiation.Uniform cell-autonomous tumorigenesis of the choroid plexus by papovavirus large T antigensSelective increase in specific alternative splice variants of tyrosinase in murine melanomas: a projected basis for immunotherapy.Expression of the mouse tyrosinase gene during embryonic development: recapitulation of the temporal regulation in transgenic miceAuthenticating cell lines in ophthalmic research laboratories.Cutaneous melanoma in genetically modified animals.G-protein-coupled receptors and melanomaGenetic predisposition of transgenic mouse melanocytes to melanoma results in malignant melanoma after exposure to a low ultraviolet B intensity nontumorigenic for normal melanocytesMalignancy of eye melanomas originating in the retinal pigment epithelium of transgenic mice after genetic ablation of choroidal melanocytesMelanosis and associated tumors in transgenic mice.Clonal coat color variation due to a transforming gene expressed in melanocytes of transgenic mice.Role of the G Protein-Coupled Receptor, mGlu1, in Melanoma Development.Roles of endothelin signaling in melanocyte development and melanoma.Modelling melanoma in mice.Transgenic Mouse Models of SV40-Induced Cancer.Genetically engineered mouse models of melanoma.Mouse melanoma models and cell lines.A cell-specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number-related expression in transgenic mice.ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.
P2860
Q26750368-263211DD-F785-4276-981D-98CFEE650AD0Q26781652-73581B29-89C1-4598-A347-CF395F5447FFQ30487265-C922771C-6BCA-4C42-979B-514BD8A459BBQ30498765-8C2C76E3-DD72-45FD-A85A-7F3C1CF2ECF1Q33288794-E14FA2DC-6780-4CBE-B898-E2CBE227F631Q33609700-E11CA725-F4D3-444A-BF32-16EB994BA0ABQ33822591-9E07FFAF-9A75-4A10-9BCE-472C15061F0CQ33885948-126D6744-B705-4BCC-ACC5-60E465B306EFQ34163697-86AE94D1-94BE-463B-8AF9-8ACE423F5D3DQ34609509-2A7FC318-CE78-4A28-8B3E-5D88DD19A60CQ35195311-3B408A07-1E96-4560-9686-19B14A30B8C1Q35283462-4A999F77-3263-4FDC-A316-E3876592C672Q35742916-2C65A4D1-18D8-40E4-9734-4AC3E01CD5D0Q35765417-1E9101DF-D200-4AF4-B4DB-87FD59B13089Q35782098-FE504291-AC5D-4CA5-9524-21BB05CFAFAAQ35932735-11717591-7960-437B-A28C-D5F6FBD5574BQ36555650-CFFE062E-9713-4102-94D0-DEFFE9F28B43Q36555941-F73B0C54-4EF4-4CA0-822D-14A6EB3317ECQ36563659-537E1F47-7703-468C-8B99-DB31114D914DQ36660661-98F68D4B-875A-40FD-A5DF-9EDD0974574AQ36668233-F8A89581-12C9-4974-B75C-50312E688331Q36696859-80226F65-A1FF-4FC8-A2CE-02FC0CDA06C2Q36743177-BC63BF7F-8268-441E-9779-EB0A8D5CEEE7Q36772676-38C66DDB-2824-4995-AAE2-FBFF19787A9CQ36922702-EC6D5F04-3D3A-47F6-9B5A-6FA63D0A5B6BQ36957655-F970E8CC-823F-4A39-800F-103CE9EC708BQ36970648-8EE91863-CE78-4786-B34E-85A1FC28F4D3Q37200841-69548A2D-FBB7-4255-9793-E850919E78ADQ37243083-EE829535-16B9-47E4-BDF9-81C8D01F5D81Q37323376-A54101CF-5E4F-4AAA-A518-0A36BF6333D8Q37361801-01E22371-D928-4FFC-8136-B340292CF3B3Q37555738-6C67C721-6EC4-49E1-98D5-07B52C4903C5Q37627169-0CADF97B-C8CA-4021-A884-05082EC5A45AQ37686567-31DA9831-3342-4B14-BABB-FA28085BA388Q37943839-1CF95BD9-CCF0-4884-8D86-78812559CC72Q38795316-09B73927-4467-4D45-8916-84F98F350264Q39329577-ABF844A5-1DEF-4291-AF16-2F04AD034F79Q39640218-9E0FA380-E56A-4012-A094-C17EA9721578Q40792436-6DF560C2-C9FA-4937-AB59-4626301136E2Q41836085-8659375B-BB26-4BF3-A8D8-10EF480B42AD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Malignant melanoma in transgenic mice.
@en
Malignant melanoma in transgenic mice.
@nl
type
label
Malignant melanoma in transgenic mice.
@en
Malignant melanoma in transgenic mice.
@nl
prefLabel
Malignant melanoma in transgenic mice.
@en
Malignant melanoma in transgenic mice.
@nl
P2093
P2860
P356
P1476
Malignant melanoma in transgenic mice
@en
P2093
P2860
P304
P356
10.1073/PNAS.88.1.164
P407
P50
P577
1991-01-01T00:00:00Z